Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) announced Wednesday that it has filed a prospectus supplement to register for resale 7,088,742 shares of its Class A common stock. The shares were issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback